查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514966

短效胰岛素市场，按药物、国家和地区划分 - 2024-2032 年行业分析、市场规模、市场份额和预测

Short-Acting Insulin Market, By Drug, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年，短效胰岛素市场规模为 75.242 亿美元，2024 年至 2032 年复合年增长率为 4.50%。

短效胰岛素市场-市场动态

政府预防糖尿病传播的措施推动市场成长

联邦、州和市各级的政府政策对于提高医疗保健的品质和安全至关重要。政策、系统和环境（PSE）的变化是预防慢性病长期策略的关键组成部分。立法法规和环境改变的目标是使健康的行为更容易实现或更可取，同时使有害的接触变得更加困难或非法。系统干预措施致力于改善机构或组织的运作以及向社区提供的服务。糖尿病是一种慢性疾病，影响超过 3000 万人。 2010 年《平价医疗法案》(ACA) 在政府、雇主和个人之间建立了共同责任范式，以确保每个人都能在其所在地区无限制地获得负担得起的高品质健康保险。

短效胰岛素市场 - 关键见解

我们的研究分析师估计，2024年至2032年全球市场将以约4.50%的复合年增长率发展。

根据药物细分，Novolog 药物细分市场将在 2023 年主导全球胰岛素市场。

按地区划分，北美是 2023 年的主要收入来源

短效胰岛素市场-細項分析：

全球短效胰岛素市场根据药物和地区进行细分。

市场根据药物分为三类：Novolog、Humalog 和 Humulin。到 2023 年，Novolog 药物领域将主导全球胰岛素市场，预计复合年增长率最高。 Novolog 是一种速效胰岛素，可与进餐时胰岛素协同作用。它的开发主要是为了获得与非糖尿病患者的胰岛素生理进餐反应更密切相关的药物动力学和药效学特征。

短效胰岛素市场 - 地理洞察

从地理来看，该市场存在于北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据哪些国家带来业务进一步划分。北美主导市场。北美作为全球最发达、最大的经济体，拥有世界一流的医疗设施，这是其市场主导地位的重要基础。

预计亚太市场在预测期内将成为全球短效胰岛素市场中最快的收入成长率；亚太地区的成功可归因于该地区医疗保健行业的惊人扩张，该行业的快速成长。

短效胰岛素市场-竞争格局：

在竞争激烈的短效胰岛素市场中，几家重要的製药公司都积极参与速效胰岛素产品的开发和行销。这些企业根据产品功效、安全性、成本和市场占有率进行竞争。短效胰岛素产业的一些重要参与者包括赛诺菲、礼来公司、诺和诺德公司、Verily 和 Sensile。

最近的发展：

2021年6月，礼来公司宣布投资4亿美元扩大产能。

目录

第一章：短效胰岛素市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按药物分類的短效胰岛素市场片段
    • 按国家/地区分類的短效胰岛素市场片段
    • 按地区分類的短效胰岛素市场片段
  • 竞争洞察

第 3 章：短效胰岛素主要市场趋势

  • 短效胰岛素市场驱动因素
    • 市场驱动因素的影响分析
  • 短效胰岛素市场限制
    • 市场限制影响分析
  • 短效胰岛素市场机会
  • 短效胰岛素市场未来趋势

第 4 章：短效胰岛素产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：短效胰岛素市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：短效胰岛素市场格局

  • 2023 年短效胰岛素市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：短效胰岛素市场 - 按药物分类

  • 概述
    • 按药物分類的细分市场份额分析
    • 诺沃洛格
    • 优泌乐
    • 优泌林

第 8 章：短效胰岛素市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美短效胰岛素主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按药物）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲短效胰岛素主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按药品）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区短效胰岛素主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区药物市场规模与预测
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲短效胰岛素主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按药品）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲短效胰岛素主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按药品）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 9 章：主要供应商分析 - 短效胰岛素产业

  • 竞争仪表板
  • 公司简介
    • Novo Nordisk AS
    • Sanofi
    • Eli Lilly and Company
    • Verily
    • Sensile
    • Others

第 10 章：360 度分析师视角

第 11 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3095

REPORT HIGHLIGHT

Short-Acting Insulin Market size was valued at USD 7,524.2 Million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.

The Short-Acting Insulin Market refers to the market segment dealing in insulin medications of a quick onset of action with a short, lengthier duration of effect. Short-acting insulin aims to provide glycemia control immediately post-meal to avoid glucose spikes due to food intake. Short-acting insulin is usually administered before or immediately after meals in order to closely mimic the body's natural supply of insulin to food intake. This is the very market of different pharmaceutical companies producing and distributing such medications to people with diabetes, so that these people may use them in a way of helping their body system regulate its blood sugar level effectively.

Short-Acting Insulin Market- Market Dynamics

Government's Initiatives to Prevent the Spread of Diabetes Drive Market Growth

Government policies at the federal, state, and municipal levels are critical to improving the quality and safety of healthcare. Changes in policy, systems, and the environment (PSE) are critical components of a long-term strategy to prevent chronic diseases. The goal of legislative regulations and environmental alterations is to make healthy behaviours more available or desirable while making detrimental exposures more difficult or illegal. Systemic interventions strive to improve an agency's or organization's operations and service delivery to the community. Diabetes is a chronic condition affecting over 30 million individuals. The Affordable Care Act of 2010 (ACA) established a shared responsibility paradigm among the government, employers, and individuals to ensure that everyone has unlimited access to affordable, high-quality health insurance in their local regions.

Short-Acting Insulin Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of approximately 4.50% from 2024 to 2032.

Based on Drug segmentation, the Novolog drugs segment will dominate the worldwide insulin market in 2023.

On the basis of region, North America was the leading revenue generator in 2023

Short-Acting Insulin Market- Segmentation Analysis:

The Global Short-Acting Insulin Market is segmented on the basis of Drug and Region.

The market is divided into three categories based on drugs: Novolog, Humalog, and Humulin. The Novolog drugs segment will dominate the worldwide insulin market in 2023, with the greatest CAGR projected. Novolog is a rapid-acting insulin that works in tandem with mealtime insulin. It was developed largely to attain pharmacokinetic as well as pharmacodynamic features that are more closely related to the physiological mealtime response of insulin in a person without diabetes.

Short-Acting Insulin Market- Geographical Insights

Geographically, this market is present in North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These zones are further split based on which countries bring business. North America dominates the market. North America, the world's most developed and largest economy, has world-class healthcare facilities, which is the major basis for its market dominance.

The Asia-Pacific market is predicted to experience the quickest revenue growth rate in the worldwide Short-Acting Insulin market during the forecast period; the Asia-Pacific region's success can be attributed to the amazing expansion of the region's healthcare industry, which has grown at a rapid pace.

Short-Acting Insulin Market- Competitive Landscape:

In the competitive Short-Acting Insulin Market, several important pharmaceutical companies are actively involved in the development and marketing of rapid-acting insulin products. These businesses compete based on product efficacy, safety, cost, and market presence. Some significant participants in the short-acting insulin industry are Sanofi, Eli Lilly & Company, Novo Nordisk AS, Verily, and Sensile.

Recent Developments:

In June 2021, Eli Lilly and Company announced a $400 million investment to expand its production capacity.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL SHORT-ACTING INSULIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Novo Nordisk AS

Sanofi

Eli Lilly and Company

Verily

Sensile

Others

GLOBAL SHORT-ACTING INSULIN MARKET, BY DRUG- MARKET ANALYSIS, 2019 - 2032

  • Novolog
  • Humalog
  • Humulin

GLOBAL SHORT-ACTING INSULIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Short-Acting Insulin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Short-Acting Insulin Market Snippet by Drug
    • 2.1.2. Short-Acting Insulin Market Snippet by Country
    • 2.1.3. Short-Acting Insulin Market Snippet by Region
  • 2.2. Competitive Insights

3. Short-Acting Insulin Key Market Trends

  • 3.1. Short-Acting Insulin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Short-Acting Insulin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Short-Acting Insulin Market Opportunities
  • 3.4. Short-Acting Insulin Market Future Trends

4. Short-Acting Insulin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Short-Acting Insulin Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Short-Acting Insulin Market Landscape

  • 6.1. Short-Acting Insulin Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Short-Acting Insulin Market - By Drug

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug, 2023 & 2032 (%)
    • 7.1.2. Novolog
    • 7.1.3. Humalog
    • 7.1.4. Humulin

8. Short-Acting Insulin Market- By Geography

  • 8.1. Introduction
    • 8.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 8.2. North America
    • 8.2.1. Overview
    • 8.2.2. Short-Acting Insulin Key Manufacturers in North America
    • 8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.2.4. North America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.2.5. U.S.
      • 8.2.5.1. Overview
      • 8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.2.5.3. U.S. Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.2.6. Canada
      • 8.2.6.1. Overview
      • 8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.2.6.3. Canada Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
  • 8.3. Europe
    • 8.3.1. Overview
    • 8.3.2. Short-Acting Insulin Key Manufacturers in Europe
    • 8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.3.4. Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.5. Germany
      • 8.3.5.1. Overview
      • 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.5.3. Germany Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.6. Italy
      • 8.3.6.1. Overview
      • 8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.6.3. Italy Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.7. United Kingdom
      • 8.3.7.1. Overview
      • 8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.7.3. United Kingdom Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.8. France
      • 8.3.8.1. Overview
      • 8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.8.3. France Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.9. Russia
      • 8.3.9.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.9.2. Russia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.10. Netherlands
      • 8.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.10.2. Netherlands Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.11. Sweden
      • 8.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.11.2. Sweden Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.12. Poland
      • 8.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.12.2. Poland Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.3.13. Rest of Europe
      • 8.3.13.1. Overview
      • 8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.13.3. Rest of the Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Overview
    • 8.4.2. Short-Acting Insulin Key Manufacturers in Asia Pacific
    • 8.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.4.4. Asia Pacific Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.5. India
      • 8.4.5.1. Overview
      • 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.5.3. India Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.6. China
      • 8.4.6.1. Overview
      • 8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.6.3. China Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.7. Japan
      • 8.4.7.1. Overview
      • 8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.7.3. Japan Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.8. South Korea
      • 8.4.8.1. Overview
      • 8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.8.3. South Korea Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.9. Australia
      • 8.4.9.1. Overview
      • 8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.9.3. Australia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.10. Thailand
      • 8.4.10.1. Overview
      • 8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.10.3. Thailand Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.11. Indonesia
      • 8.4.11.1. Overview
      • 8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.11.3. Indonesia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.12. Philippines
      • 8.4.12.1. Overview
      • 8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.12.3. Philippines Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.4.13. Rest of APAC
      • 8.4.13.1. Overview
      • 8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.13.3. Rest of APAC Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
  • 8.5. Latin America
    • 8.5.1. Overview
    • 8.5.2. Short-Acting Insulin Key Manufacturers in Latin America
    • 8.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.5.4. Latin America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.5.5. Brazil
      • 8.5.5.1. Overview
      • 8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.5.3. Brazil Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.5.6. Mexico
      • 8.5.6.1. Overview
      • 8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.6.3. Mexico Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.5.7. Argentina
      • 8.5.7.1. Overview
      • 8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.7.3. Argentina Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.5.8. Colombia
      • 8.5.8.1. Overview
      • 8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.8.3. Colombia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.5.9. Rest of LATAM
      • 8.5.9.1. Overview
      • 8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.9.3. Rest of LATAM Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Overview
    • 8.6.2. Short-Acting Insulin Key Manufacturers in Middle East and Africa
    • 8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.6.4. Middle East and Africa Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.5. Saudi Arabia
      • 8.6.5.1. Overview
      • 8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.5.3. Saudi Arabia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.6. United Arab Emirates
      • 8.6.6.1. Overview
      • 8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.6.3. United Arab Emirates Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.7. Israel
      • 8.6.7.1. Overview
      • 8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.7.3. Israel Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.8. Turkey
      • 8.6.8.1. Overview
      • 8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.8.3. Turkey Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.9. Algeria
      • 8.6.9.1. Overview
      • 8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.9.3. Algeria Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.10. Egypt
      • 8.6.10.1. Overview
      • 8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.10.3. Egypt Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 8.6.11. Rest of MEA
      • 8.6.11.1. Overview
      • 8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.11.3. Rest of MEA Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)

9. Key Vendor Analysis- Short-Acting Insulin Industry

  • 9.1. Competitive Dashboard
  • 9.2. Company Profiles
    • 9.2.1. Novo Nordisk AS
    • 9.2.2. Sanofi
    • 9.2.3. Eli Lilly and Company
    • 9.2.4. Verily
    • 9.2.5. Sensile
    • 9.2.6. Others

10. 360 Degree Analyst View

11. Appendix

  • 11.1. Research Methodology
  • 11.2. References
  • 11.3. Abbreviations
  • 11.4. Disclaimer
  • 11.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Short-Acting Insulin Market: Drug Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug
  • TABLE Global Short-Acting Insulin Market, by Drug 2019-2032 (USD Million)
  • TABLE TABLE TABLE Short-Acting Insulin Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Short-Acting Insulin Market, by Region 2019-2032 (USD Million)
  • TABLE North America Short-Acting Insulin Market, by Country, 2019-2032 (UD Million)
  • TABLE North America Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
  • TABLE Europe Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
  • TABLE Asia Pacific Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
  • TABLE Latin America Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)

T

List of Figures

  • FIGURE Short-Acting Insulin Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Drug segment market share analysis, 2023 & 2032
  • FIGURE Drug segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Short-Acting Insulin Market share and leading players, 2023
  • FIGURE Europe Short-Acting Insulin Market share and leading players, 2023
  • FIGURE Asia Pacific Short-Acting Insulin Market share and leading players, 2023
  • FIGURE Latin America Short-Acting Insulin Market share and leading players, 2023
  • FIGURE Middle East and Africa Short-Acting Insulin Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Short-Acting Insulin Market share analysis by country, 2023
  • FIGURE Germany Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Short-Acting Insulin Market share analysis by country, 2023
  • FIGURE India Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Short-Acting Insulin Market share analysis by country, 2023
  • FIGURE Brazil Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Short-Acting Insulin Market share analysis by country, 2023
  • FIGURE Saudi Arabia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)